Inc.;H. Lee Moffitt Cancer Center and Research Institute
发明人:
List, Alan F.,Wei, Sheng
申请号：
AU2015339032
公开号：
AU2015339032A1
申请日:
2015.10.30
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Disclosed are compositions and methods for targeted treatment of TLR9-expressing cancers, such as primary human MDS progenitors and hematopoietic stem cell (HSC), as well as lung and breast cancers. In particular, multispecific, multivalent antibodies are disclosed that are able to engage T-cells to destroy TLR9-expressing malignant cells.
